# Piedmont Columbus Regional Midtown – FDA Inspection, Jun 4, 2019

Source: https://www.keypedia.com/records/fda_inspections/piedmont-columbus-regional-midtown/557ed37b-a0d3-4286-929d-a43a1a26ccb5
Source feed: FDA_Inspections

> FDA inspection 1096339 of Piedmont Columbus Regional Midtown, June 04, 2019. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1096339
- Company Name: Piedmont Columbus Regional Midtown
- Inspection Date: 2019-06-04
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1328606 - 2026-07-16
- [FDA Inspection 1243509 - 2024-07-11](https://www.keypedia.com/records/fda_inspections/piedmont-columbus-regional-midtown/94385774-4d5b-4601-9efa-ae9e5a4d975c)
- FDA Inspection 970689 - 2016-05-18
- FDA Inspection 868637 - 2014-02-25

## Related Officers

- [Company Rep](https://www.keypedia.com/people/cordelia-j-brammer/57662881-a90a-461d-ac4d-8c1bc18a333e)

Company: https://www.keypedia.com/companies/piedmont-columbus-regional-midtown/0bf69c4a-0e3c-4d1a-baff-0548ded6abc6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d